MAGE revisited: Evaluation of glucose variability with once daily glargine vs NPH insulin in type 2 diabetes

被引：0
|
作者：
Silvani, G. [1 ]
Acquati, S. [1 ]
Manini, R. [1 ]
Ragazzini, C. [1 ]
Taroni, S. [1 ]
Donadio, F. [1 ]
Buci, L. [1 ]
Gagliardi, L. [1 ]
Tartaglia, A. [1 ]
Nizzoli, M. [1 ]
机构：
[1] GB Morgagni L Pierantoni Hosp, Forli, Italy
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
978
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Comparison of Glucose Variability Assessed by a Continuous Glucose Monitoring System in Patients with Type 2 Diabetes Switched from NPH Insulin to Insulin Glargine: The COBIN2 Study
    Kvapil, Milan
    Rusavy, Zdenek
    Krivska, Bohumila
    Janickovazdars, Denisa
    Krcma, Michal
    DIABETES, 2011, 60 : A284 - A284
  • [12] A three-month comparison between multiple daily NPH and once daily glargine insulin administration in intensive replacement of basal insulin in type 1 diabetes mellitus
    Rossetti, P
    Pampanelli, S
    Costa, E
    Torlone, E
    Brunetti, P
    Bolli, GB
    DIABETES, 2002, 51 : A54 - A54
  • [13] Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemenis
    Bretzel, Reinhard G.
    Linn, Thomas
    DIABETES, 2006, 55 : A111 - A111
  • [14] Initiation of insulin glargine in patients with Type 2 diabetes suboptimally controlled on once- or twice-daily NPH insulin: results from the AT.LANTUS trial
    Fulcher, GR
    Storms, F
    Shutler, S
    Leperlier, C
    Gomis, R
    Davies, M
    DIABETOLOGIA, 2004, 47 : A272 - A272
  • [15] Nocturnal glucose variability in patients using bedtime glargine and NPH insulin
    Mackowiak, L
    JaBlonka, E
    Broderick, O
    Goodman, G
    DIABETES, 2003, 52 : A126 - A126
  • [16] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
    McEwan, Phil
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    Currie, Craig J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
  • [17] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [18] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    DIABETES CARE, 2005, 28 (04) : 950 - 955
  • [19] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [20] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
12345